Industry: Healthcare
Published Date: November-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 169
Report ID: PMRREP34917
1. Executive Summary
1.1. Middle East & Africa Point-of-Care Diagnostics Market Snapshot, 2024 and 2031
1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Middle East & Africa Sectorial Outlook
2.3.2. Middle East & Africa GDP Growth Outlook
2.3.3. Middle East & Africa Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Product Adoption Analysis
3.2. Epidemiology - Infectious Diseases and Chronic Conditions
3.3. Technology Assessment
3.4. Regulatory Landscape
3.5. Value Chain Analysis
3.6. Key Deals and Mergers
3.7. PESTLE Analysis
3.8. Porter’s Five Force Analysis
4. Price Trend Analysis, 2019 - 2031
4.1. Key Highlights
4.2. Key Factors Impacting Product Prices
4.3. Pricing Analysis, By Product
4.4. Regional Prices and Preferences
5. Middle East & Africa Point-of-Care Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
5.1. Key Highlights
5.1.1. Market Volume (Units) Projections
5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
5.1.3. Absolute $ Opportunity
5.2. Market Size (US$ Bn) Analysis and Forecast
5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2022
5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023-2031
5.3. Middle East & Africa Point-of-Care Diagnostics Market Outlook: Product
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product, 2019 - 2022
5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2023 - 2031
5.3.3.1. Infectious Disease
5.3.3.2. Glucose Monitoring
5.3.3.3. Hepatitis C
5.3.3.4. HIV
5.3.3.5. Sexually Transmitted Disease (STD)
5.3.3.6. Influenza
5.3.3.7. Tropical Disease
5.3.3.8. Healthcare-Associated Infection (HAI)
5.3.3.9. Pregnancy and Fertility
5.3.3.10. Respiratory Infection
5.3.3.11. Other Infectious Disease
5.3.3.12. Tumor/Cancer Marker
5.3.3.13. Cardiometabolic
5.3.3.14. Cholesterol
5.3.3.15. Coagulation
5.3.3.16. Hematology
5.3.3.17. Urinalysis
5.4. Market Attractiveness Analysis: Product
5.5. Middle East & Africa Point-of-Care Diagnostics Market Outlook: Prescription Mode
5.5.1. Introduction / Key Findings
5.5.2. Historical Market Size (US$ Bn) Analysis, By Prescription Mode, 2019 - 2022
5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Prescription Mode, 2023 - 2031
5.5.3.1. Prescription-based
5.5.3.2. OTC
5.6. Market Attractiveness Analysis: Prescription Mode
5.7. Middle East & Africa Point-of-Care Diagnostics Market Outlook: Type
5.7.1. Introduction / Key Findings
5.7.2. Historical Market Size (US$ Bn) Analysis, By Type, 2019 - 2022
5.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2023 - 2031
5.7.3.1. Consumables and Kits
5.7.3.2. Software and Services
5.7.3.3. Devices
5.7.3.4. Accessories
5.8. Market Attractiveness Analysis: Type
5.9. Middle East & Africa Point-of-Care Diagnostics Market Outlook: End User
5.9.1. Introduction / Key Findings
5.9.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019 - 2022
5.9.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
5.9.3.1. Hospitals
5.9.3.2. Ambulatory Care Settings
5.9.3.3. Home Care
5.9.3.4. Research Laboratories
5.9.3.5. Others
5.10. Market Attractiveness Analysis: End User
6. Middle East & Africa Point-of-Care Diagnostics Market Outlook: Country
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Country, 2019 - 2022
6.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Country, 2023 - 2031
6.3.1. Kingdom of Saudi Arabia
6.3.2. United Arab Emirates
6.3.3. South Africa
6.3.4. Rest of GCC
6.3.5. Rest of Middle East & Africa
6.4. Market Attractiveness Analysis: Country
7. Kingdom of Saudi Arabia Filtered Hearing Protection Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019 - 2022
7.3.1. By Product
7.3.2. By Prescription Mode
7.3.3. By Type
7.3.4. By End User
7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2023 - 2031
7.4.1. Infectious Disease
7.4.2. Glucose Monitoring
7.4.3. Hepatitis C
7.4.4. HIV
7.4.5. Sexually Transmitted Disease (STD)
7.4.6. Influenza
7.4.7. Respiratory Infection
7.4.8. Tropical Disease
7.4.9. Healthcare-Associated Infection (HAI)
7.4.10. Pregnancy and Fertility
7.4.11. Tumor/Cancer Marker
7.4.12. Cardiometabolic
7.4.13. Cholesterol
7.4.14. Coagulation
7.4.15. Hematology
7.4.16. Urinalysis
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Prescription Mode, 2023 - 2031
7.5.1. Prescription-Based
7.5.2. OTC
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2023 - 2031
7.6.1. Consumables and Kits
7.6.2. Software and Services
7.6.3. Devices
7.6.4. Accessories
7.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
7.7.1. Hospitals
7.7.2. Ambulatory Care Settings
7.7.3. Home Care
7.7.4. Research Laboratories
7.7.5. Others
7.8. Market Attractiveness Analysis
8. United Arab Emirates Filtered Hearing Protection Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019 - 2022
8.3.1. By Product
8.3.2. By Prescription Mode
8.3.3. By Type
8.3.4. By End User
8.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2023 - 2031
8.4.1. Infectious Disease
8.4.2. Glucose Monitoring Products
8.4.3. Hepatitis C
8.4.4. HIV
8.4.5. Sexually Transmitted Disease (STD)
8.4.6. Influenza
8.4.7. Respiratory Infection
8.4.8. Tropical Disease
8.4.9. Healthcare-Associated Infection (HAI)
8.4.10. Pregnancy and Fertility
8.4.11. Tumor/Cancer Marker
8.4.12. Cardiometabolic
8.4.13. Cholesterol
8.4.14. Coagulation
8.4.15. Hematology
8.4.16. Urinalysis
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Prescription Mode, 2023 - 2031
8.5.1. Prescription-Based
8.5.2. OTC
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2023 - 2031
8.6.1. Consumables and Kits
8.6.2. Software and Services
8.6.3. Devices
8.6.4. Accessories
8.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
8.7.1. Hospitals
8.7.2. Ambulatory Care Settings
8.7.3. Home Care
8.7.4. Research Laboratories
8.7.5. Others
8.8. Market Attractiveness Analysis
9. Rest of GCC Filtered Hearing Protection Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019 - 2022
9.3.1. By Product
9.3.2. By Prescription Mode
9.3.3. By Type
9.3.4. By End User
9.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2023 - 2031
9.4.1. Infectious Disease
9.4.2. Glucose Monitoring Products
9.4.3. Hepatitis C
9.4.4. HIV
9.4.5. Sexually Transmitted Disease (STD)
9.4.6. Influenza
9.4.7. Respiratory Infection
9.4.8. Tropical Disease
9.4.9. Healthcare-Associated Infection (HAI)
9.4.10. Pregnancy and Fertility
9.4.11. Tumor/Cancer Marker
9.4.12. Cardiometabolic
9.4.13. Cholesterol
9.4.14. Coagulation
9.4.15. Hematology
9.4.16. Urinalysis
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Prescription Mode, 2023 - 2031
9.5.1. Prescription-Based
9.5.2. OTC
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2023 - 2031
9.6.1. Consumables and Kits
9.6.2. Software and Services
9.6.3. Devices
9.6.4. Accessories
9.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
9.7.1. Hospitals
9.7.2. Ambulatory Care Settings
9.7.3. Home Care
9.7.4. Research Laboratories
9.7.5. Others
9.8. Market Attractiveness Analysis
10. Rest of Middle East & Africa Filtered Hearing Protection Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019 - 2022
10.3.1. By Product
10.3.2. By Prescription Mode
10.3.3. By Type
10.3.4. By End User
10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2023 - 2031
10.4.1. Infectious Disease
10.4.2. Glucose Monitoring Products
10.4.3. Hepatitis C
10.4.4. HIV
10.4.5. Sexually Transmitted Disease (STD)
10.4.6. Influenza
10.4.7. Respiratory Infection
10.4.8. Tropical Disease
10.4.9. Healthcare-Associated Infection (HAI)
10.4.10. Pregnancy and Fertility
10.4.11. Tumor/Cancer Marker
10.4.12. Cardiometabolic
10.4.13. Cholesterol
10.4.14. Coagulation
10.4.15. Hematology
10.4.16. Urinalysis
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Prescription Mode, 2023 - 2031
10.5.1. Prescription-based
10.5.2. OTC
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Type, 2023 - 2031
10.6.1. Consumables and Kits
10.6.2. Software and Services
10.6.3. Devices
10.6.4. Accessories
10.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
10.7.1. Hospitals
10.7.2. Ambulatory Care Settings
10.7.3. Home Care
10.7.4. Research Laboratories
10.7.5. Others
10.8. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2023
11.2. Market Structure
11.2.1. Competition Intensity Mapping by Market
11.2.2. Competition Dashboard
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. QIAGEN
11.3.1.1. Overview
11.3.1.2. Segments and Products
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Danaher Corporation
11.3.3. F. Hoffmann-La Roche Ltd
11.3.4. BD (Becton Dickinson)
11.3.5. Abbott
11.3.6. BIOMÉRIEUX
11.3.7. Nova Biomedical
11.3.8. Werfen
11.3.9. Trividia Health, Inc.
11.3.10. Siemens Healthcare Private Limited
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations